Pigmentary Disorders Exchange Symposium

Pathogenesis & Clinical Features of Photodamage: What Clinicians Should Know
PhotodamageThere’s more to aging skin than photodamage, explains Dr. Zoe D. Draelos, president of Dermatology Consulting Services. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Draelos explains the latest understanding in the pathogenesis and clinical features of aging skin, including photodamage. Learn how the exposome leads to signs of aging an …
Photodamage
The Relevance of Skin Color & Skin Type in Procedural Treatments
procedrual treatmentsEven routine medical dermatology procedures can induce pigmentary alterations in darker skin tones, notes Dr. Andrew Alexis, co-chair of Skin of Color Update, and vice-chair for diversity and inclusion for the Weill Cornell Medical College Department of Dermatology. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Alexis outlines how skin co …
procedrual treatments
Understanding Acquired Macular Dermal Hyperpigmentation Disorders
Acquired Macular Dermal HyperpigmentationMacular dermal hyperpigmentation is an umbrella term, explains Dr. Pearl E. Grimes, symposium chair and clinical professor of dermatology at the University of California, Los Angeles. In an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium, Dr. Grimes outlines the most common types of macular dermal hyperpigmentation and the factors that may be at play …
Acquired Macular Dermal Hyperpigmentation
Using Cosmeceuticals for Pigmentary Disorders | Expert Insights from Dr. Heather Woolery-Lloyd
CosmeceuticalsThe many alternatives to hydroquinone make this an exciting time for using cosmeceuticals to treat pigmentary disorders, according to Dr. Heather Woolery-Lloyd, director of the Skin of Color Division at the University of Miami Miller School of Medicine’s Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery. In an interview with Next Steps in Derm, in partnership with Pigmentary Diso …
Cosmeceuticals
Latest Advances in the Pathogenesis of Vitiligo | Expert Insights from Dr. John Harris
vitiligoUnderstanding the pathogenesis of vitiligo can help determine new treatment targets. Dr. John Harris, professor and chair of the dermatology department at UMass Chan Medical School, shared the latest advances in understanding what causes vitiligo in an interview with Next Steps in Derm, in partnership with Pigmentary Disorders Exchange Symposium. Watch as Dr. Harris explains the role of the immune …
vitiligo